尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the complete record of transactions filed by Snisarenko John, Directeur Commercial. Director active across 2 companies, notably Oyster Point Pharma, Inc.. Aggregated, 2 filings have been published. History available since 9 January 2022. The latest transaction was filed on 9 January 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
John Snisarenko is the Chief Commercial Officer at Oyster Point Pharma, Inc. He is responsible for the commercial strategy and sales growth of the company. With a strong background in the pharmaceutical sector, Snisarenko plays a key role in business expansion and achieving commercial objectives.